global health

Dear Research Advocate, On the Hill: Major deadlines (end of fiscal year, hitting the debt limit) and conflicting policy priorities (reconciliation and infrastructure bills) have triggered a frenetic atmosphere in Congress, leaving actions needed to address major national challenges very much up in the air. Today, both chambers passed a stopgap spending bill (“Continuing Resolution” or CR) flat-funding the government through early December; the measure is headed to the President’s desk to be signed before midnight. Here is an editable Tweet thanking Congressional leaders for preventing a government shutdown but urging them to act; not wait for the CR to expire before finalizing FY22...
Dear Research Advocate, The remainder of 2021 will test whether our nation heeds a warning that speakers at our National Health Research Forum last week stressed again and again: the U.S. can no longer conduct business as usual as existential threats mount. Instead, we need to gather the courage to see clearly, act boldly, and embrace change. Mikael Dolsten, MD, PhD, chief scientific officer and president, Worldwide Research, Development, and Medical, Pfizer Inc, and a Research!America board member, offered particularly compelling comments in this regard at our Forum: “I think we need to invest more in understanding: what does it take to create an innovation culture for the country? What...
Americans across much of the U.S. might feel as if they are finally waking from a bad dream. COVID-19 cases are at their lowest levels since March 2020, vaccines are widely available, workplaces are reopening, social life has resumed, and domestic travel neared an all-time high over the July 4 holiday weekend. This “return to normal” is far from the case in many areas: countries from India to the United Kingdom to Argentina have experienced recent spikes in COVID-19 cases, with sometimes devastating results. First in India and then in the U.K., spikes in infection rates resulting in new lockdown restrictions were driven by the Delta variant – a mutation of the original SARS-CoV-2 virus. The...
Dear Research Advocate, “Hopefully, the urgency that everyone is seeing around COVID-19 will translate into bigger investments for global health vaccines.” — Dr. Peter Hotez Renowned vaccinologist and prolific author Dr. Peter Hotez, Dean of the National School of Tropical Medicine at Baylor College of Medicine and Co-director of the Texas Children’s Hospital Center for Vaccine Development, joined us yesterday for an alliance member call. Dr. Hotez spoke about the history of life-saving vaccines, COVID-19 vaccine development, and the alarming spread of the novel coronavirus across the southern hemisphere. He also spoke about the anti-science and anti-vaccine movements in our country and...
Being in the middle of a global pandemic feels unsettling and frightening. Part of that fear is rooted in the unknown, because we still have many unanswered questions: fundamental information researchers don’t know about the coronavirus and how viruses like it will act in the future. At the moment, we’re rightly focused on urgent issues such as securing personal protective equipment and ventilators. But we need more research, because to win the battle we need to understand our enemy so that better diagnosis, treatment, and prevention will become a reality. As I wrote recently in USA Today , “Rarely in recent memory has it been this difficult to see beyond the next day. ... But that is...
The summer 2019 edition of the Research!America newsletter , The Research Advocate, is now online. In this newsletter, you'll find information about the recent Wellcome Global Monitor report on global attitudes about science, Research!America's recent briefing on patient-centered research on rural heart health, the measles outbreak, and much more.
Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, was treating patients with HIV/AIDS before the disease had a name. In the early 1980’s, a period he describes as the dark years of his professional career, half of the patients he saw would be dead within twelve months, and the medical community had no idea what was killing them. At the Washington Post Live event Transformers:Health on June 11, Dr. Fauci described the progress that has been made in HIV treatment, as well as the challenges that must still be addressed to tackle the disease in the United States and globally, in a discussion entitled “Chasing a cure: the global outlook on HIV/AIDS” ...
Dear Research Advocate, Congress is officially out of session this week, but because negotiations to determine whether budget caps are raised are continuing, advocacy must continue as well. More than fifty organizations signed on to an AAAS-led letter to Congressional leaders asking them to prioritize federal research investments, raise the budget caps, and provide sustainable and robust investments for scientific research in Fiscal Year 2020. Now it’s time for more individual hands on this deck. Sign the Raise the Caps petition here . One of the concerns Members of Congress are likely hearing about back home is a disease once declared eliminated -- measles. More than 500 cases have been...
Dear Research Advocate: We saw the power of a robust public health force, integrated public health programs, and an innovative R&D pipeline this week as the World Health Organization declared the recent Ebola outbreak contained . Think of the lives and dollars that could be saved if global health were accorded the priority it deserves on a sustained basis, rather than gaining traction only when crises are upon us! We have updated our Top Ten Reasons to invest in global R&D. Use this terrific Kaiser Family Foundation primer on all things global health policy-related, and make the case for global health research as a strategic asset on social media or with your congressional...
Flu pandemics and other disease outbreaks underscore the need for vaccines and public health infrastructures to protect individuals against global health threats, said leaders representing government, scientific societies and advocacy groups at a briefing hosted by Research!America and the American Society for Microbiology (ASM) at the Newseum in Washington, D.C. on May 21. The program coincided with the opening of the Smithsonian’s exhibit Outbreak: Epidemics in a Connected World. Seventy-percent of Americans say the federal government should do more to educate the public about global disease outbreaks and the risk to the U.S., according to a new national survey commissioned by Research!...

Pages